Fig. 6From: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicineThe inhibitory rates of the four compounds against H1N1 influenza virus determined byĀ Real-Time PCR assay regarding to the post-exposure antiviral activity. According to the one-way ANOVA followed by Tukeyās multiple comparisons test, there were significant differences among the groups (pā<ā0.0001), except for ZnO-NPs vs. ZnO-PEG-NPs at the concentration of 25āĪ¼g/mL. Error bars represent the confidence interval for the mean (nā=ā3) at the 95% levelBack to article page